At the end of January, the Ivy League, a National Collegiate Athletic Association (NCAA) Division I conference, announced that it is opting out of the settlement reached in House v. NCAA. The settlement, which was reached as...more
As state legislatures introduce legislation expanding the reach of their antitrust laws and state attorneys general ramp up their use of antitrust investigations and litigation, the legal landscape continues to become more...more
2/28/2025
/ Antitrust Provisions ,
California ,
Competition ,
Constitutional Challenges ,
Healthcare ,
Jurisdiction ,
Patents ,
Pharmaceutical Industry ,
Settlement ,
State Attorneys General ,
Unfair Competition
The U.S. Federal Trade Commission (FTC) took the next step in its long-standing effort to encourage lower prices and increase competition in the pharmaceutical industry. As part of the Biden administration’s whole government...more
2/12/2024
/ Bayh-Dole Act ,
Biden Administration ,
Biosimilars ,
Competition ,
Drug Distribution ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Food & Drug Regulations ,
Generic Drugs ,
Healthcare ,
Healthcare Reform ,
March-in-Rights ,
NIST ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Regulatory Agenda
As a sport, golf has rarely, if ever, been described as "cutting edge." But in the courtroom, golf may be at the forefront of the latest antitrust developments. In the coming months, the legal war unfolding in professional...more